Global Ophthalmic Therapeutics/Drug Market Growth (Status and Outlook) 2024-2031

Report ID: 1339096 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Ophthalmic Therapeutics/Drug Market Size 2017-2028
        2.1.2 Ophthalmic Therapeutics/Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Ophthalmic Therapeutics/Drug Segment by Type
        2.2.1 Anti-allergy
        2.2.2 Anti-VEGF Agents
        2.2.3 Anti-inflammatory
        2.2.4 Anti-glaucoma
        2.2.5 Others
    2.3 Ophthalmic Therapeutics/Drug Market Size by Type
        2.3.1 Ophthalmic Therapeutics/Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Ophthalmic Therapeutics/Drug Market Size Market Share by Type (2017-2022)
    2.4 Ophthalmic Therapeutics/Drug Segment by Application
        2.4.1 Dry Eye
        2.4.2 Allergies
        2.4.3 Glaucoma
        2.4.4 Infection
        2.4.5 Retinal Disorders
        2.4.6 Uveitis
        2.4.7 Others
    2.5 Ophthalmic Therapeutics/Drug Market Size by Application
        2.5.1 Ophthalmic Therapeutics/Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Ophthalmic Therapeutics/Drug Market Size Market Share by Application (2017-2022)
3 Ophthalmic Therapeutics/Drug Market Size by Player
    3.1 Ophthalmic Therapeutics/Drug Market Size Market Share by Players
        3.1.1 Global Ophthalmic Therapeutics/Drug Revenue by Players (2020-2022)
        3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2020-2022)
    3.2 Global Ophthalmic Therapeutics/Drug Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Ophthalmic Therapeutics/Drug by Regions
    4.1 Ophthalmic Therapeutics/Drug Market Size by Regions (2017-2022)
    4.2 Americas Ophthalmic Therapeutics/Drug Market Size Growth (2017-2022)
    4.3 APAC Ophthalmic Therapeutics/Drug Market Size Growth (2017-2022)
    4.4 Europe Ophthalmic Therapeutics/Drug Market Size Growth (2017-2022)
    4.5 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Ophthalmic Therapeutics/Drug Market Size by Country (2017-2022)
    5.2 Americas Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022)
    5.3 Americas Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Ophthalmic Therapeutics/Drug Market Size by Region (2017-2022)
    6.2 APAC Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022)
    6.3 APAC Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Ophthalmic Therapeutics/Drug by Country (2017-2022)
    7.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022)
    7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Ophthalmic Therapeutics/Drug by Region (2017-2022)
    8.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022)
    8.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Ophthalmic Therapeutics/Drug Market Forecast
    10.1 Global Ophthalmic Therapeutics/Drug Forecast by Regions (2023-2028)
        10.1.1 Global Ophthalmic Therapeutics/Drug Forecast by Regions (2023-2028)
        10.1.2 Americas Ophthalmic Therapeutics/Drug Forecast
        10.1.3 APAC Ophthalmic Therapeutics/Drug Forecast
        10.1.4 Europe Ophthalmic Therapeutics/Drug Forecast
        10.1.5 Middle East & Africa Ophthalmic Therapeutics/Drug Forecast
    10.2 Americas Ophthalmic Therapeutics/Drug Forecast by Country (2023-2028)
        10.2.1 United States Ophthalmic Therapeutics/Drug Market Forecast
        10.2.2 Canada Ophthalmic Therapeutics/Drug Market Forecast
        10.2.3 Mexico Ophthalmic Therapeutics/Drug Market Forecast
        10.2.4 Brazil Ophthalmic Therapeutics/Drug Market Forecast
    10.3 APAC Ophthalmic Therapeutics/Drug Forecast by Region (2023-2028)
        10.3.1 China Ophthalmic Therapeutics/Drug Market Forecast
        10.3.2 Japan Ophthalmic Therapeutics/Drug Market Forecast
        10.3.3 Korea Ophthalmic Therapeutics/Drug Market Forecast
        10.3.4 Southeast Asia Ophthalmic Therapeutics/Drug Market Forecast
        10.3.5 India Ophthalmic Therapeutics/Drug Market Forecast
        10.3.6 Australia Ophthalmic Therapeutics/Drug Market Forecast
    10.4 Europe Ophthalmic Therapeutics/Drug Forecast by Country (2023-2028)
        10.4.1 Germany Ophthalmic Therapeutics/Drug Market Forecast
        10.4.2 France Ophthalmic Therapeutics/Drug Market Forecast
        10.4.3 UK Ophthalmic Therapeutics/Drug Market Forecast
        10.4.4 Italy Ophthalmic Therapeutics/Drug Market Forecast
        10.4.5 Russia Ophthalmic Therapeutics/Drug Market Forecast
    10.5 Middle East & Africa Ophthalmic Therapeutics/Drug Forecast by Region (2023-2028)
        10.5.1 Egypt Ophthalmic Therapeutics/Drug Market Forecast
        10.5.2 South Africa Ophthalmic Therapeutics/Drug Market Forecast
        10.5.3 Israel Ophthalmic Therapeutics/Drug Market Forecast
        10.5.4 Turkey Ophthalmic Therapeutics/Drug Market Forecast
        10.5.5 GCC Countries Ophthalmic Therapeutics/Drug Market Forecast
    10.6 Global Ophthalmic Therapeutics/Drug Forecast by Type (2023-2028)
    10.7 Global Ophthalmic Therapeutics/Drug Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Alcon
        11.1.1 Alcon Company Information
        11.1.2 Alcon Ophthalmic Therapeutics/Drug Product Offered
        11.1.3 Alcon Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Alcon Main Business Overview
        11.1.5 Alcon Latest Developments
    11.2 Johnson and Johnson Vision Care, Inc.
        11.2.1 Johnson and Johnson Vision Care, Inc. Company Information
        11.2.2 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Offered
        11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Johnson and Johnson Vision Care, Inc. Main Business Overview
        11.2.5 Johnson and Johnson Vision Care, Inc. Latest Developments
    11.3 Bausch & Lomb Incorporated
        11.3.1 Bausch & Lomb Incorporated Company Information
        11.3.2 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Offered
        11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Bausch & Lomb Incorporated Main Business Overview
        11.3.5 Bausch & Lomb Incorporated Latest Developments
    11.4 Novartis AG
        11.4.1 Novartis AG Company Information
        11.4.2 Novartis AG Ophthalmic Therapeutics/Drug Product Offered
        11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Novartis AG Main Business Overview
        11.4.5 Novartis AG Latest Developments
    11.5 Merck Sharp & Dohme Corp.
        11.5.1 Merck Sharp & Dohme Corp. Company Information
        11.5.2 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Offered
        11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Merck Sharp & Dohme Corp. Main Business Overview
        11.5.5 Merck Sharp & Dohme Corp. Latest Developments
    11.6 Regeneron Pharmaceuticals Inc.
        11.6.1 Regeneron Pharmaceuticals Inc. Company Information
        11.6.2 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Offered
        11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Regeneron Pharmaceuticals Inc. Main Business Overview
        11.6.5 Regeneron Pharmaceuticals Inc. Latest Developments
    11.7 Allergan
        11.7.1 Allergan Company Information
        11.7.2 Allergan Ophthalmic Therapeutics/Drug Product Offered
        11.7.3 Allergan Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Allergan Main Business Overview
        11.7.5 Allergan Latest Developments
    11.8 Pfizer Inc.
        11.8.1 Pfizer Inc. Company Information
        11.8.2 Pfizer Inc. Ophthalmic Therapeutics/Drug Product Offered
        11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Pfizer Inc. Main Business Overview
        11.8.5 Pfizer Inc. Latest Developments
    11.9 Valeant
        11.9.1 Valeant Company Information
        11.9.2 Valeant Ophthalmic Therapeutics/Drug Product Offered
        11.9.3 Valeant Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Valeant Main Business Overview
        11.9.5 Valeant Latest Developments
    11.10 Bayer AG
        11.10.1 Bayer AG Company Information
        11.10.2 Bayer AG Ophthalmic Therapeutics/Drug Product Offered
        11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Bayer AG Main Business Overview
        11.10.5 Bayer AG Latest Developments
    11. Santen Pharmaceuticals Co. Ltd
        11.11.1 Santen Pharmaceuticals Co. Ltd Company Information
        11.11.2 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Offered
        11.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Santen Pharmaceuticals Co. Ltd Main Business Overview
        11.11.5 Santen Pharmaceuticals Co. Ltd Latest Developments
    11.12 Genentech, Inc.
        11.12.1 Genentech, Inc. Company Information
        11.12.2 Genentech, Inc. Ophthalmic Therapeutics/Drug Product Offered
        11.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Genentech, Inc. Main Business Overview
        11.12.5 Genentech, Inc. Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Ophthalmic Therapeutics/Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Anti-allergy
    Table 3. Major Players of Anti-VEGF Agents
    Table 4. Major Players of Anti-inflammatory
    Table 5. Major Players of Anti-glaucoma
    Table 6. Major Players of Others
    Table 7. Ophthalmic Therapeutics/Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Type (2017-2022)
    Table 10. Ophthalmic Therapeutics/Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Application (2017-2022)
    Table 13. Global Ophthalmic Therapeutics/Drug Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Player (2020-2022)
    Table 15. Ophthalmic Therapeutics/Drug Key Players Head office and Products Offered
    Table 16. Ophthalmic Therapeutics/Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Ophthalmic Therapeutics/Drug Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Ophthalmic Therapeutics/Drug Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Ophthalmic Therapeutics/Drug Market Size Market Share by Country (2017-2022)
    Table 23. Americas Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Ophthalmic Therapeutics/Drug Market Size Market Share by Type (2017-2022)
    Table 25. Americas Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Ophthalmic Therapeutics/Drug Market Size Market Share by Application (2017-2022)
    Table 27. APAC Ophthalmic Therapeutics/Drug Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Ophthalmic Therapeutics/Drug Market Size Market Share by Region (2017-2022)
    Table 29. APAC Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Ophthalmic Therapeutics/Drug Market Size Market Share by Type (2017-2022)
    Table 31. APAC Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Ophthalmic Therapeutics/Drug Market Size Market Share by Application (2017-2022)
    Table 33. Europe Ophthalmic Therapeutics/Drug Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Ophthalmic Therapeutics/Drug Market Size Market Share by Country (2017-2022)
    Table 35. Europe Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Ophthalmic Therapeutics/Drug Market Size Market Share by Type (2017-2022)
    Table 37. Europe Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Ophthalmic Therapeutics/Drug Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Ophthalmic Therapeutics/Drug
    Table 46. Key Market Challenges & Risks of Ophthalmic Therapeutics/Drug
    Table 47. Key Industry Trends of Ophthalmic Therapeutics/Drug
    Table 48. Global Ophthalmic Therapeutics/Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Ophthalmic Therapeutics/Drug Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Ophthalmic Therapeutics/Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Ophthalmic Therapeutics/Drug Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Ophthalmic Therapeutics/Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Ophthalmic Therapeutics/Drug Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Alcon Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 55. Alcon Ophthalmic Therapeutics/Drug Product Offered
    Table 56. Alcon Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Alcon Main Business
    Table 58. Alcon Latest Developments
    Table 59. Johnson and Johnson Vision Care, Inc. Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 60. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Offered
    Table 61. Johnson and Johnson Vision Care, Inc. Main Business
    Table 62. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Johnson and Johnson Vision Care, Inc. Latest Developments
    Table 64. Bausch & Lomb Incorporated Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 65. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Offered
    Table 66. Bausch & Lomb Incorporated Main Business
    Table 67. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Bausch & Lomb Incorporated Latest Developments
    Table 69. Novartis AG Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 70. Novartis AG Ophthalmic Therapeutics/Drug Product Offered
    Table 71. Novartis AG Main Business
    Table 72. Novartis AG Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Novartis AG Latest Developments
    Table 74. Merck Sharp & Dohme Corp. Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 75. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Offered
    Table 76. Merck Sharp & Dohme Corp. Main Business
    Table 77. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Merck Sharp & Dohme Corp. Latest Developments
    Table 79. Regeneron Pharmaceuticals Inc. Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 80. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Offered
    Table 81. Regeneron Pharmaceuticals Inc. Main Business
    Table 82. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Regeneron Pharmaceuticals Inc. Latest Developments
    Table 84. Allergan Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 85. Allergan Ophthalmic Therapeutics/Drug Product Offered
    Table 86. Allergan Main Business
    Table 87. Allergan Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. Allergan Latest Developments
    Table 89. Pfizer Inc. Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 90. Pfizer Inc. Ophthalmic Therapeutics/Drug Product Offered
    Table 91. Pfizer Inc. Main Business
    Table 92. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Pfizer Inc. Latest Developments
    Table 94. Valeant Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 95. Valeant Ophthalmic Therapeutics/Drug Product Offered
    Table 96. Valeant Main Business
    Table 97. Valeant Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Valeant Latest Developments
    Table 99. Bayer AG Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 100. Bayer AG Ophthalmic Therapeutics/Drug Product Offered
    Table 101. Bayer AG Main Business
    Table 102. Bayer AG Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. Bayer AG Latest Developments
    Table 104. Santen Pharmaceuticals Co. Ltd Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 105. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Offered
    Table 106. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. Santen Pharmaceuticals Co. Ltd Main Business
    Table 108. Santen Pharmaceuticals Co. Ltd Latest Developments
    Table 109. Genentech, Inc. Details, Company Type, Ophthalmic Therapeutics/Drug Area Served and Its Competitors
    Table 110. Genentech, Inc. Ophthalmic Therapeutics/Drug Product Offered
    Table 111. Genentech, Inc. Main Business
    Table 112. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. Genentech, Inc. Latest Developments
List of Figures
    Figure 1. Ophthalmic Therapeutics/Drug Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Ophthalmic Therapeutics/Drug Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Type in 2021
    Figure 7. Ophthalmic Therapeutics/Drug in Dry Eye
    Figure 8. Global Ophthalmic Therapeutics/Drug Market: Dry Eye (2017-2022) & ($ Millions)
    Figure 9. Ophthalmic Therapeutics/Drug in Allergies
    Figure 10. Global Ophthalmic Therapeutics/Drug Market: Allergies (2017-2022) & ($ Millions)
    Figure 11. Ophthalmic Therapeutics/Drug in Glaucoma
    Figure 12. Global Ophthalmic Therapeutics/Drug Market: Glaucoma (2017-2022) & ($ Millions)
    Figure 13. Ophthalmic Therapeutics/Drug in Infection
    Figure 14. Global Ophthalmic Therapeutics/Drug Market: Infection (2017-2022) & ($ Millions)
    Figure 15. Ophthalmic Therapeutics/Drug in Retinal Disorders
    Figure 16. Global Ophthalmic Therapeutics/Drug Market: Retinal Disorders (2017-2022) & ($ Millions)
    Figure 17. Ophthalmic Therapeutics/Drug in Uveitis
    Figure 18. Global Ophthalmic Therapeutics/Drug Market: Uveitis (2017-2022) & ($ Millions)
    Figure 19. Ophthalmic Therapeutics/Drug in Others
    Figure 20. Global Ophthalmic Therapeutics/Drug Market: Others (2017-2022) & ($ Millions)
    Figure 21. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Application in 2021
    Figure 22. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Player in 2021
    Figure 23. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Regions (2017-2022)
    Figure 24. Americas Ophthalmic Therapeutics/Drug Market Size 2017-2022 ($ Millions)
    Figure 25. APAC Ophthalmic Therapeutics/Drug Market Size 2017-2022 ($ Millions)
    Figure 26. Europe Ophthalmic Therapeutics/Drug Market Size 2017-2022 ($ Millions)
    Figure 27. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size 2017-2022 ($ Millions)
    Figure 28. Americas Ophthalmic Therapeutics/Drug Value Market Share by Country in 2021
    Figure 29. Americas Ophthalmic Therapeutics/Drug Consumption Market Share by Type in 2021
    Figure 30. Americas Ophthalmic Therapeutics/Drug Market Size Market Share by Application in 2021
    Figure 31. United States Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Canada Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Mexico Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Brazil Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 35. APAC Ophthalmic Therapeutics/Drug Market Size Market Share by Region in 2021
    Figure 36. APAC Ophthalmic Therapeutics/Drug Market Size Market Share by Application in 2021
    Figure 37. China Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Japan Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Korea Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Southeast Asia Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 41. India Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Australia Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Europe Ophthalmic Therapeutics/Drug Market Size Market Share by Country in 2021
    Figure 44. Europe Ophthalmic Therapeutics/Drug Market Size Market Share by Type in 2021
    Figure 45. Europe Ophthalmic Therapeutics/Drug Market Size Market Share by Application in 2021
    Figure 46. Germany Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 47. France Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 48. UK Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Italy Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 50. Russia Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Market Share by Region in 2021
    Figure 52. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Market Share by Type in 2021
    Figure 53. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size Market Share by Application in 2021
    Figure 54. Egypt Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 55. South Africa Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 56. Israel Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 57. Turkey Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 58. GCC Country Ophthalmic Therapeutics/Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 59. Americas Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 60. APAC Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 61. Europe Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 62. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 63. United States Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 64. Canada Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 65. Mexico Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 66. Brazil Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 67. China Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 68. Japan Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 69. Korea Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 70. Southeast Asia Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 71. India Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 72. Australia Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 73. Germany Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 74. France Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 75. UK Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 76. Italy Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 77. Russia Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 78. Spain Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 79. Egypt Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 80. South Africa Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 81. Israel Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 82. Turkey Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
    Figure 83. GCC Countries Ophthalmic Therapeutics/Drug Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Ophthalmic Therapeutics/Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Ophthalmic Therapeutics/Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Ophthalmic Therapeutics/Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports